Alexion Pharmaceuticals, Inc. (ALXN) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $115.63, down from yesterday’s close by -0.37%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental AnalysisNo amount of research is complete without a bird’s eye view of the financial data. Alexion Pharmaceuticals, Inc. (ALXN) currently trades with a market capitalization of $25.79 Billion. That value represents a market adjusting for revenues that have been growing by 7.50 % on a quarterly year/year basis as of the company’s last quarterly report.
     (adsbygoogle = window.adsbygoogle || []).push({});
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For ALXN, the company currently has $550 Million of cash on the books, which is offset by $167 Million current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $864.69 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $1.28 on a per share basis this quarter. Perhaps, that suggests something about why 96.74% of the outstanding share supply is held by institutional investors.Technical AnalysisIt’s important to check the technicals to get a sense of how ALXN has been acting. Looking at the stock’s movement on the chart, Alexion Pharmaceuticals, Inc. recorded a 52-week high of $149.34. It is now trading 33.71% off that level. The stock is trading $139.06 its 50-day moving average by 23.43%. The stock carved out a 52-week low down at $96.18.In recent action, Alexion Pharmaceuticals, Inc. (ALXN) has made a move of -19.58% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 23.7, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 2.26% with $222.44 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of ALXN.